J.B. Chemicals & Pharma Share Price Target For Tomorrow, Next Week & Next Month
J. B. Chemicals & Pharmaceuticals Limited | |||
 | Price: ₹1,632.60 (+0.44%) | ||
| 52 Week Low: ₹1,385.75 52 Week High: ₹2,030.00 | |||
| Market Capital: 26,451.56 Crore (Largecap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
J.B. Chemicals & Pharma Stock Comparison: J.B. Chemicals & Pharma vs Alembic Pharma | J.B. Chemicals & Pharma vs Neuland Laboratories | J.B. Chemicals & Pharma vs Piramal Pharma | J.B. Chemicals & Pharma vs Laurus Labs | J.B. Chemicals & Pharma vs Narayana Hrudayalaya | J.B. Chemicals & Pharma vs Dr. Lal Path labs | |||
Share Price HistoryJBCHEPHARM FinancialsTomorrow TargetYearly TargetsDividend HistoryBonus HistorySplit History
Show Table of Contents
J.B. Chemicals & Pharma Recent Performance
Over the past 411 trading days, the value of J.B. Chemicals & Pharma's stock has gained ₹179.85 (+12.38%). On 07 Nov 2023, one share was worth ₹1452.75 and by 09 Jul 2025, the value jumped to ₹1632.60. During this period it created a highest high of ₹2030.00 and lowest low of ₹1371.00.
J.B. Chemicals & Pharma Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 1737.4 (+6.41%) | Price Action: 18 Jun 2025 High |
| Tomorrow Target 2 | 1719 (+5.29%) | Price Action: 06 Jun 2025 High |
| Tomorrow Target 1 | 1701.9 (+4.24%) | Price Action: 02 Jun 2025 High |
| Current Price | 1632.60 | J.B. Chemicals & Pharma's share price as of 09 Jul 2025 |
| Stop Loss 1 | 1567.75 (-3.98%) | Price Action: 19 Mar 2025 Low |
| Stop Loss 2 | 1551 (-5%) | Price Action: 13 Mar 2025 High |
| Stop Loss 3 | 1534 (-6.04%) | Price Action: 11 Apr 2025 Low |
Summary
09 Jul 2025: J.B. Chemicals & Pharma finished the day at ₹1632.60, gaining ₹7.20 (+0.44%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -6.04% to 6.42% with:
- Target prices: ₹1701.9 to ₹1737.4
- Support levels: ₹1567.75 to ₹1534
- Recent high: ₹1636.70
- Recent low: ₹1615.10
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
J.B. Chemicals & Pharma Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 1679.1 (+2.84%) | Price Action: 03 Jun 2025 Low |
| Next Week Target 2 | 1658.9 (+1.61%) | Price Action: 17 Apr 2025 High |
| Next Week Target 1 | 1641.76 (+0.56%) | Fibonacci Extension Level 23.60% |
| Current Price | 1632.60 | J.B. Chemicals & Pharma's share price as of 09 Jul 2025 |
| Stop Loss 1 | 1629.83 (-0.17%) | Price Action: May 2024 Low |
| Stop Loss 2 | 1613.05 (-1.2%) | Price Action: 17 Feb 2025 Low |
| Stop Loss 3 | 1595.95 (-2.25%) | Price Action: 11 Apr 2025 High |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -2.24% to 2.85% with:
- Upper targets: ₹1641.76 to ₹1679.1
- Support levels: ₹1629.83 to ₹1595.95
J.B. Chemicals & Pharma Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 1758.9 (+7.73%) | Technical Indicator: MA250 |
| Next Month Target 2 | 1739.9 (+6.57%) | Price Action: 13 Jun 2025 High |
| Next Month Target 1 | 1722.5 (+5.5%) | Price Action: 12 Jun 2025 Low |
| Current Price | 1632.60 | J.B. Chemicals & Pharma's share price as of 09 Jul 2025 |
| Stop Loss 1 | 1608 (-1.51%) | Price Action: 10 Mar 2025 High |
| Stop Loss 2 | 1589.5 (-2.64%) | Price Action: 11 Feb 2025 Low |
| Stop Loss 3 | 1572.4 (-3.69%) | Price Action: 07 Mar 2025 Low |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -3.69% to 7.74% with:
- Target range: ₹1722.5 to ₹1758.9
- Support levels: ₹1608 to ₹1572.4
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
